Quick Answer
RxSight, Inc. reported Total Assets of $311.81 million for the year ending 2025.
- RxSight, Inc. showed a decrease of -2.1% in Total Assets from 2024 to 2025.
- This data is from RxSight, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $94.89 million | Q3 2021: $203.74 million | Q1 2022: $177.06 million | Q2 2022: $166.71 million | Q3 2022: $155.71 million | Q1 2023: $202.53 million | Q2 2023: $195.26 million | Q3 2023: $181.85 million | Q1 2024: $183.17 million | Q2 2024: $305.50 million | Q3 2024: $310.47 million | Q1 2025: $313.04 million | Q2 2025: $309.01 million | Q3 2025: $308.53 million.
- Over the full 6 years of available data (2020 to 2025), RxSight, Inc.'s Total Assets has grown by 209.7%.
- Historical annual values: Fiscal year 2025: $311.81 million | Fiscal year 2024: $318.56 million | Fiscal year 2023: $182.55 million | Fiscal year 2022: $150.16 million | Fiscal year 2021: $192.72 million | Fiscal year 2020: $100.68 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: